A detailed history of Algert Global LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Algert Global LLC holds 7,271 shares of ABBV stock, worth $1.34 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,271
Holding current value
$1.34 Million
% of portfolio
0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $1.19 Million - $1.45 Million
7,271 New
7,271 $1.44 Million
Q3 2022

Nov 15, 2022

BUY
$134.21 - $153.93 $281,438 - $322,791
2,097 New
2,097 $281,000
Q4 2019

Feb 18, 2020

SELL
$72.13 - $90.25 $389,213 - $486,989
-5,396 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $102,279 - $122,969
-1,624 Reduced 23.13%
5,396 $409,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $461,214 - $589,539
7,020 New
7,020 $510,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $325B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.